One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care Project

Sponsor
University of Washington (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05905640
Collaborator
National Institute of Mental Health (NIMH) (NIH), Kenya Medical Research Institute (Other), Jomo Kenyatta University of Agriculture and Technology (Other)
2,400
2
48

Study Details

Study Description

Brief Summary

The goal of this cluster randomized study is to understand if using a One stop PrEP delivery model can improve the efficiency of PrEP service delivery, reduce the cost of providing PrEP and allow continuation on PrEP. The investigators will evaluate data from men and women ≥15 years of age unknown to be living with HIV seeking PrEP services at public health facilities in western Kenya.

Condition or Disease Intervention/Treatment Phase
  • Other: Method of PrEP delivery and consultation
N/A

Detailed Description

This study will evaluate the effectiveness of one-stop PrEP services in 12 public health facilities in Kenya. The core implementation strategies to optimize one-stop PrEP care will include training of healthcare providers, technical assistance, joint clinic supervision with the county health officials, and abstraction of program data regarding PrEP initiations and continuations including characteristics of PrEP users for quality improvement. Within this large program, the study team will recruit a nested observational cohort to obtain detailed complementary individual clinical, behavioral, and mental health outcomes (including for clients who discontinue PrEP).

Study Design

Study Type:
Interventional
Anticipated Enrollment :
2400 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Cluster randomized trial of twelve public health clinics assigned 1:1 to implement either the intervention of One stop PrEP care pathway or usual clinic flow as control.Cluster randomized trial of twelve public health clinics assigned 1:1 to implement either the intervention of One stop PrEP care pathway or usual clinic flow as control.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
One-stop PrEP Care Pathway to Simplify PrEP Delivery in Kenya: The One-Stop PrEP Care Project
Anticipated Study Start Date :
Jul 31, 2023
Anticipated Primary Completion Date :
Jul 31, 2026
Anticipated Study Completion Date :
Jul 31, 2027

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control arm- Usual PrEP care pathway

At clinics that will serve as contemporaneous control clinics, eligible persons will receive PrEP according to the current client flow, which typically involves multiple room consultations. Quality improvement strategies will be promoted throughout the implementation period.

Other: Intervention Arm- One Stop PrEP care pathway

In a one-stop arm, the number of client consultation rooms in the PrEP care pathway will be reduced to a single consultation room. All core PrEP services that include HIV testing, risk assessment, clinical review PrEP initiation, prescription, dispensing, and follow-up will be performed in a one-stop consultation with a single provider. Quality improvement strategies will be promoted throughout the implementation period.

Other: Method of PrEP delivery and consultation
All core PrEP services that include HIV testing, risk assessment, clinical review PrEP initiation, prescription, dispensing, and follow-up will be performed in a one-stop consultation with a single provider.

Outcome Measures

Primary Outcome Measures

  1. PrEP initiation [Years 2-4 of the study, up to 36 months.]

    PrEP initiation will be measured by client start of PrEP use documented on the ministry of health (MOH) tools. Data will be abstracted from MOH tools by project dedicated staff from up to 2400 persons newly initiating PrEP at the participating clinics.

  2. PrEP continuation [up to 12 months of PrEP use.]

    PrEP continuation will determined by clinic visit attendance and pharmacy PrEP refills records obtained by abstraction of MOH clinic records.

  3. PrEP adherence [Years 2-4 of the study, up to 36 months.]

    PrEP adherence will be measured objectively by quantification of drug levels in dried blood spots obtained at random subset visits from clients returning for PrEP refills.

  4. Acceptability [Throughout the study period, up to 36 months]

    Acceptability will be determined as the perception among clients, providers, and stakeholder that one-stop PrEP services is agreeable to them. Mixed methods assessments, including user and provider surveys and qualitative interviews with users and providers will be utilized to measure acceptability. The Proctors implementation framework will be utilized to organize outcomes and to understand acceptability of one-stop and quality improvement measures at the user, clinic, and provider level. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence adoption.

  5. Adoption [Throughout the study period, up to 36 months]

    Adoption will be determined as the proportion and characteristics of facilities adopting one-stop services. Mixed methods assessments, including provider surveys and qualitative interviews with users and providers will be utilized to measure adoption. The Proctors implementation framework will be utilized to organize outcomes and to understand adoption of one-stop and quality improvement measures at the clinic and provider level. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence adoption.

  6. Fidelity [Throughout the study period, up to 36 months]

    Fidelity will be defined as the degree to which one-stop pathway and quality improvement measures are implemented as planned. Checklists and technical assistant reports will be used to study how implementation of one-stop pathway and quality improvement measures are implemented per protocol at provider and clinic level. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence adoption.

  7. Total client wait time and staff time spent on PrEP services [Throughout the study period, up to 36 months]

    Efficiency will be defined as client wait time and staff time spent on PrEP services. Time will be done by observing at least 50 clinical visits per arm to assess wait time and staff time spent on counseling, HIV testing, clinical review, and PrEP provision

  8. Satisfaction with services [Throughout the study period, up to 36 months]

    Satisfaction will be defined ad fulfillment or happiness with one-stop service experience. Within the program we will use cross-sectional quantitative exit surveys administered to random clients at clinic to understand quality of care services and satisfaction with services.

  9. Sustainability [up to 12 months after technical assistance support is scaled back]

    Sustainability will be defined as the number of clinics using one-stop at 6, 12 months after TA. Checklists and technical assistant reports will be used to document implementation of one-stop after technical assistance support is scaled back The Proctors implementation framework will be use organize implementation outcomes. Investigators will comprehensively triangulate all data sources to understand how system, provider, and client factors interact to influence continuation of PrEP.

Secondary Outcome Measures

  1. Incremental cost of one-stop PrEP services, including costs averted, and reduced client wait times. [up to 36 months.]

    Micro-costing studies will be conducted during the implementation of one-stop PrEP delivery in intervention clinics as well as the current practice arm using activity-based approaches for costs incurred (start-up activities, clinic-wide training, recruitment, PrEP service delivery, including HIV testing, PrEP drugs, STI treatment, creatinine testing, and follow-up) and direct program costs averted (health costs saved by averting HIV infections, personnel costs averted as result of providing PrEP in one stop).

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ≥15 years of age

  • Accessing PrEP services at implementing clinics.

  • Eligible for PrEP per Kenya national guidelines

For in-depth and key delivery informant interviews

  • Able and willing to provide consent

  • Provides services at participating clinics (healthcare providers)

  • Key policy maker

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Washington
  • National Institute of Mental Health (NIMH)
  • Kenya Medical Research Institute
  • Jomo Kenyatta University of Agriculture and Technology

Investigators

  • Principal Investigator: Kenneth Mugwanya, MBChB, MS, PhD, University of Washington

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Kenneth K Mugwanya, Assistant Professor: Global Health, University of Washington
ClinicalTrials.gov Identifier:
NCT05905640
Other Study ID Numbers:
  • STUDY00015873
  • R01MH129234-01A1
First Posted:
Jun 15, 2023
Last Update Posted:
Jun 15, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kenneth K Mugwanya, Assistant Professor: Global Health, University of Washington
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2023